Literature DB >> 7034793

Effectiveness of multiple muscle-site EMG biofeedback and relaxation training in reducing the aversiveness of cancer chemotherapy.

T G Burish, C D Shartner, J N Lyles.   

Abstract

A 44-year-old female cancer patient was given progressive muscle relaxation training and multiple muscle-site EMG biofeedback to reduce the conditioned negative responses she had apparently developed to her chemotherapy treatments. Following three baseline chemotherapy sessions, the patient was given relaxation training and biofeedback during four consecutive chemotherapy treatments and was asked to practice her relaxation skills daily in the hospital or at home. After the patient felt able to relax on her own, relaxation training and biofeedback were terminated and three follow-up sessions were held. Results indicated that during the chemotherapy sessions in which the patient received relaxation training and biofeedback, she showed reductions in physiological arousal (EMG, pulse rate, systolic blood pressure, and diastolic blood pressure) and reported feeling less anxious and nauseated. Moreover, these changes were maintained during the follow-up sessions. These results suggest that relaxation training plus multiple muscle-site biofeedback may be an effective adjunctive procedure for reducing some of the adverse side effects of cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7034793     DOI: 10.1007/bf00998737

Source DB:  PubMed          Journal:  Biofeedback Self Regul        ISSN: 0363-3586


  14 in total

1.  Nausea, vomiting and cancer treatment.

Authors:  J G Harris
Journal:  CA Cancer J Clin       Date:  1978 Jul-Aug       Impact factor: 508.702

2.  The use of self-hypnosis by children with cancer.

Authors:  W LaBaw; C Holton; K Tewell; D Eccles
Journal:  Am J Clin Hypn       Date:  1975-04

3.  Letter: Cancer treatment needs better antiemetics.

Authors:  V M Whitehead
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

4.  MEASUREMENT OF EXPERIMENTALLY INDUCED AFFECTS.

Authors:  M ZUCKERMAN; B LUBIN; L VOGEL; E VALERIUS
Journal:  J Consult Psychol       Date:  1964-10

5.  Supportive hypnotherapy during the radical treatment of malignancies.

Authors:  C R Dempster; P Balson; B T Whalen
Journal:  Int J Clin Exp Hypn       Date:  1976-01

Review 6.  Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Authors:  D D Von Hoff; R Schilsky; C M Reichert; R L Reddick; M Rozencweig; R C Young; F M Muggia
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

7.  Relaxation therapy and high blood pressure.

Authors:  C B Taylor; J W Farquhar; E Nelson; S Agras
Journal:  Arch Gen Psychiatry       Date:  1977-03

8.  Neuropsychiatric effects of chemotherapeutic agents for cancer.

Authors:  L G Peterson; M K Popkin
Journal:  Psychosomatics       Date:  1980-02       Impact factor: 2.386

9.  History and development of cisplatin in the management of malignant disease.

Authors:  P Eustace
Journal:  Cancer Nurs       Date:  1980-10       Impact factor: 2.592

10.  Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.

Authors:  A E Chang; D J Shiling; R C Stillman; N H Goldberg; C A Seipp; I Barofsky; R M Simon; S A Rosenberg
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391

View more
  5 in total

Review 1.  Anticipatory nausea and vomiting.

Authors:  Matti S Aapro; Alexander Molassiotis; Ian Olver
Journal:  Support Care Cancer       Date:  2004-12-15       Impact factor: 3.603

Review 2.  Anticipatory nausea and vomiting due to chemotherapy.

Authors:  Charles Kamen; Mohamedtaki A Tejani; Kavita Chandwani; Michelle Janelsins; Anita R Peoples; Joseph A Roscoe; Gary R Morrow
Journal:  Eur J Pharmacol       Date:  2013-10-21       Impact factor: 4.432

Review 3.  Anticipatory nausea and vomiting.

Authors:  Joseph A Roscoe; Gary R Morrow; Matti S Aapro; Alexander Molassiotis; Ian Olver
Journal:  Support Care Cancer       Date:  2010-08-30       Impact factor: 3.603

4.  Stress reduction prior to oral surgery.

Authors:  S Johnson; K Chapman; G Huebner
Journal:  Anesth Prog       Date:  1984 Jul-Aug

Review 5.  Advances in behavioral intervention in comprehensive cancer treatment.

Authors:  W H Redd
Journal:  Support Care Cancer       Date:  1994-03       Impact factor: 3.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.